Enveric Biosciences Management
Management criteria checks 3/4
Enveric Biosciences' CEO is Joseph Tucker, appointed in Sep 2021, has a tenure of 3.17 years. total yearly compensation is $577.07K, comprised of 78.1% salary and 21.9% bonuses, including company stock and options. directly owns 0.33% of the company’s shares, worth $9.86K. The average tenure of the management team and the board of directors is 3.2 years and 2.3 years respectively.
Key information
Joseph Tucker
Chief executive officer
US$577.1k
Total compensation
CEO salary percentage | 78.1% |
CEO tenure | 3.2yrs |
CEO ownership | 0.3% |
Management average tenure | 3.2yrs |
Board average tenure | 2.3yrs |
Recent management updates
Recent updates
An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued
Jul 02Enveric Biosciences to raise $8M in stock offering for corporate use
Jul 25Enveric Biosciences Goes Psychedelic With MagicMed Acquisition
May 31Enveric Biosciences announces $10M registered direct offering
Jan 12CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$10m |
Jun 30 2024 | n/a | n/a | -US$11m |
Mar 31 2024 | n/a | n/a | -US$15m |
Dec 31 2023 | US$577k | US$451k | -US$17m |
Sep 30 2023 | n/a | n/a | -US$23m |
Jun 30 2023 | n/a | n/a | -US$23m |
Mar 31 2023 | n/a | n/a | -US$19m |
Dec 31 2022 | US$826k | US$362k | -US$19m |
Sep 30 2022 | n/a | n/a | -US$52m |
Jun 30 2022 | n/a | n/a | -US$52m |
Mar 31 2022 | n/a | n/a | -US$50m |
Dec 31 2021 | US$3m | US$92k | -US$49m |
Compensation vs Market: Joseph's total compensation ($USD577.07K) is about average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Joseph's compensation has been consistent with company performance over the past year.
CEO
Joseph Tucker (55 yo)
3.2yrs
Tenure
US$577,065
Compensation
Dr. Joseph Tucker, Ph D., has been a Director of Enveric Biosciences, Inc. since September 16, 2021. Dr. Tucker has been the Chief Executive Officer of Enveric Biosciences, Inc. since September 16, 2021.D...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 3.2yrs | US$577.07k | 0.33% $ 9.9k | |
Chief Financial Officer | 1.7yrs | US$435.31k | 0.074% $ 2.2k | |
Chief Innovation Officer | 3.2yrs | US$282.06k | 0.22% $ 6.6k |
3.2yrs
Average Tenure
60yo
Average Age
Experienced Management: ENVB's management team is considered experienced (3.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 3.2yrs | US$577.07k | 0.33% $ 9.9k | |
Independent Chairman of the Board | 2.4yrs | US$175.00k | 0.54% $ 16.1k | |
Independent Director | less than a year | no data | 0.31% $ 9.4k | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Independent Director | 2.3yrs | US$57.50k | 0.55% $ 16.4k | |
Chairman of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Independent Non-Employee Director | 3.9yrs | US$52.00k | 0.54% $ 16.2k | |
Independent Non-Employee Director | 3.9yrs | US$59.00k | 0.54% $ 16.2k |
2.3yrs
Average Tenure
64yo
Average Age
Experienced Board: ENVB's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.